• Jan 28, 2026 The Pharmagellan Guide To Biotech Forecasting And Valuation gement, patents, and potential biosimilar competition. By modeling each phase separately, analysts can assign probability-weighted cash flows, 3 reflecting the inherent risk at each stage. 2. Incorporating Probabilities By Gwendolyn Torp Jr.
